Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists

Bibliographic Details
Main Authors: Monica Carpenedo, Arianna Zappaterra, Beatrice Ferrari, Giulia Cotilli
Format: Article
Language:English
Published: Mattioli1885 2023-02-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
Online Access:http://www.mjhid.org/index.php/mjhid/article/view/5240
_version_ 1811162585325633536
author Monica Carpenedo
Arianna Zappaterra
Beatrice Ferrari
Giulia Cotilli
author_facet Monica Carpenedo
Arianna Zappaterra
Beatrice Ferrari
Giulia Cotilli
author_sort Monica Carpenedo
collection DOAJ
first_indexed 2024-04-10T06:32:52Z
format Article
id doaj.art-6216a5596556445894a24402d89ea85c
institution Directory Open Access Journal
issn 2035-3006
language English
last_indexed 2024-04-10T06:32:52Z
publishDate 2023-02-01
publisher Mattioli1885
record_format Article
series Mediterranean Journal of Hematology and Infectious Diseases
spelling doaj.art-6216a5596556445894a24402d89ea85c2023-03-01T05:22:58ZengMattioli1885Mediterranean Journal of Hematology and Infectious Diseases2035-30062023-02-0115110.4084/MJHID.2023.021Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor AgonistsMonica CarpenedoArianna Zappaterra0Beatrice Ferrari1Giulia Cotilli2A.O San Gerardo di Monza e Università di Milano Bicocca, Hematology and Transplant Unit via Pergolesi 33. Monza, IT 20900A.O San Gerardo di Monza e Università di Milano Bicocca, Hematology and Transplant Unit via Pergolesi 33. Monza, IT 20900A.O San Gerardo di Monza e Università di Milano Bicocca, Hematology and Transplant Unit via Pergolesi 33. Monza, IT 20900http://www.mjhid.org/index.php/mjhid/article/view/5240Chronic ITPITPthrombopoietinnew agentsNew DrugsRefractory ITP
spellingShingle Monica Carpenedo
Arianna Zappaterra
Beatrice Ferrari
Giulia Cotilli
Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists
Mediterranean Journal of Hematology and Infectious Diseases
Chronic ITP
ITP
thrombopoietin
new agents
New Drugs
Refractory ITP
title Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists
title_full Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists
title_fullStr Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists
title_full_unstemmed Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists
title_short Sequential Use of Efgartigimod and Romiplostim Restored Platelet Response in Two Multirefractory Thrombocytopenic Patients, Previously Treated with Thrombopoietin Receptor Agonists
title_sort sequential use of efgartigimod and romiplostim restored platelet response in two multirefractory thrombocytopenic patients previously treated with thrombopoietin receptor agonists
topic Chronic ITP
ITP
thrombopoietin
new agents
New Drugs
Refractory ITP
url http://www.mjhid.org/index.php/mjhid/article/view/5240
work_keys_str_mv AT monicacarpenedo sequentialuseofefgartigimodandromiplostimrestoredplateletresponseintwomultirefractorythrombocytopenicpatientspreviouslytreatedwiththrombopoietinreceptoragonists
AT ariannazappaterra sequentialuseofefgartigimodandromiplostimrestoredplateletresponseintwomultirefractorythrombocytopenicpatientspreviouslytreatedwiththrombopoietinreceptoragonists
AT beatriceferrari sequentialuseofefgartigimodandromiplostimrestoredplateletresponseintwomultirefractorythrombocytopenicpatientspreviouslytreatedwiththrombopoietinreceptoragonists
AT giuliacotilli sequentialuseofefgartigimodandromiplostimrestoredplateletresponseintwomultirefractorythrombocytopenicpatientspreviouslytreatedwiththrombopoietinreceptoragonists